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Abstract
Background: Norway is interested in implementing remote patient monitoring (RPM) within
primary health services. This systematic review will first identify the types of RPM that are of
interest to Norwegian health authorities, then synthesize the effects of RPM on clinical health
and health service utilization outcomes among adults with chronic diseases. Methods:We will
perform systematic literature searches in multiple databases, using RPM-related searches, such
as telemedicine, telemonitoring, and eHealth. Based on what research exists, the review will be
selected from a cascadingmenu of review types.Methodological quality will be assessed through
appropriate checklists, while the quality of the evidence will be assessed through Grading of
Recommendations Assessment, Development, and Evaluation. Discussion: This flexible proto-
col specifies the production of different possible types of reviews of RPM. It is anticipated that
the results of the review will inform the development of effective RPM programs to the most
appropriate chronic disease groups.
Introduction
What is the problem?
Norway, as many other industrialized countries, has an aging population with increasing bur-
dens of chronic diseases. While this increased longevity is the positive result of advances in
medical technology that prevent mortality from acute diseases, chronic conditions continue
to accumulate with age. Sixty-year-old Norwegians can expect to live another 22 years, and
10 of those years will be burdened by morbidity from chronic diseases (Knudsen et al., 2017).
The preferred approach to long-term management of chronic diseases is within a chronic
care model, in which patients receive well-coordinated, flexible, and proactive care, driven
by regular assessments (Wagner et al., 2001; Helse- og omsorgsdepartement, 2013; WHO,
2016). Regular assessments after the onset of chronic diseases are crucial to monitor treatment
progress, prevent deterioration, and prevent the development of additional diseases, injuries,
and complications. With more frequent patient assessments, there is more accurate and indi-
vidualized treatment decisions; with real-time data, patients and providers are more likely to be
aware of the need for health services before deterioration (Wagner et al., 2001). However, fre-
quent face-to-face meetings with health care providers are burdensome for both the patient and
the provider and are often neither prioritized nor feasible, especially for lower-risk patients.
Unfortunately, there is little evidence that chronic diseases are being managed within a
chronic care model: from 2014 to 2017, the amount of preventable hospitalizations among
chronically ill Norwegians increased by 5% from 2014 to 2017 (Helsedirektoratet, 2019).
The Directorate of Health (DoH) has suggested that appropriate follow-up of these patients
by their general practitioners could help prevent overuse of hospital and other specialist
health services (Helsedirektoratet, 2019). Other countries such as the United Kingdom and
New Zealand have also begun focusing on managing patients with complex or multiple chronic
conditions in primary care (Adan et al., 2020; McGeoch et al., 2019).
What is the solution?
Ideally, patients could transmit health data without seeing providers, and this data could be sent
and evaluated often enough to initiate interventions or treatment adjustments before the
patient’s health status becomes acute. Remote patient monitoring (RPM; also referred to as
telemonitoring, remote care, telehealth, home monitoring, and telerehabilitation) uses these
strategies. The collection and transmission of data outside the traditional points of care contact
allow patients to remain at home while receiving follow-up and to receive follow-up only if their
condition warrants it. This should increase equality in health care access for patients living in
rural areas and patients with physical, economic, or other mobility barriers.
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Given the increasing prevalence of chronic conditions in the
Norwegian population along with an increasing amount of unnec-
essary specialist health services utilization, it is not feasible to
expect that specialist health care providers will be able to provide
the type of frequent, preventative, and non-acute monitoring that
many patients could benefit from. The government has therefore pri-
oritized piloting RPM as well as other types of chronic care and care
coordination programs within the primary health services, adminis-
trated by the municipalities (Helse- og omsorgsdepartement, 2013;
Helse- og omsorgsdepartement, 2015; Helsedirektoratet, 2017).
The intention is to curb preventable and unnecessary consumption
of specialist health services, such as hospital and emergency room
admissions, to situate primary care providers in the center of chronic
disease management and to allow people to remain at home and
within their social networks. The Norwegian DoH has developed
a specific definition of RPM that describes exactly the type of proc-
esses that they consider aremost relevant forNorway. This definition
is described further in theMethods, but briefly, data are transmitted
from a non-institutionalized patient to a provider remotely, and the
provider evaluates the data manually and contacts the patient, or the
data are automatically evaluated (i.e., by the device), but providers are
contacted for follow-up if values are concerning.
Why do we need this systematic review?
It is unclear whether the large amount of research on monitoring,
broadly defined, is applicable to Norway, given the specific type of
RPM that the DoH is interested in further developing. For exam-
ple, one recent overview of 19 systematic reviews (SRs) of the effect
on heart failure outcomes concluded that ‘remote monitoring’
strategies reduce mortality (Bashi et al., 2017). However, the over-
view included mobile phone applications that did not involve
providers. This is a type of remote monitoring that does not meet
the DoH definition of RPM. Another overview of four SRs of
‘telehealth remote patient monitoring’ among patients with type 2
diabetes found a statistically significant, but small, reduction in
blood glucose levels (Lee et al., 2018). This overview also included
automated programs and therefore does not meet the DoH defini-
tion of RPM. Lastly, a 2014 overview identified 13 reviews of ‘tele-
monitoring’ of chronic disease patients served in primary care, but
with telemonitoring not further defined (Purcell et al., 2014). In
our planned SR, we will carefully assess the types of RPM identified
against the DoH definition of RPM in order to synthesize evidence
that is most relevant and applicable to Norway. We will also exam-
ine the extent to which the reviews and their meta-analyses provide
coherent, mutually supportive evidence, based on the idea that
such evidence is stronger than incoherent/inconsistent evidence
(Mickenautsch, 2012).
Objectives
This is a protocol for aSR. We have three objectives:
1. Identify overviews of SRs, and SRs, that report clinical and
health service utilization outcomes following RPM of chroni-
cally ill patients in the primary health care sector.
2. Summarize the evidence on the effect of RPMon the health status
of chronically ill patients and their consumption of health and
care services.




The DoH definition of RPM is specific enough that existing
overviews and SRs may not meet inclusion criteria. This protocol
therefore specifies five potential review types, based on the search
results, and described according to the PRISMA-P checklist, avail-
able in Appendix 1 (Shamseer et al., 2015). In this section, we pro-
vide a brief description of the procedure, while further details
follow in the sections below.
As shown in Figure 1, the type of review we conduct will be
determined by the existing research. The order of priority is from
the top down, that is, if the search results in one or more overview
of SRs that we assess as having high methodological quality (see
Quality evaluation below), we will conduct an overview of over-
views (review type A). If no overview of reviews are found but
we instead find four or more SRs, we will write an overview of
SRs (Review B). If we find fewer than four SRs, we will write a
three-page synopsis of each of these (Review C). If we do not iden-
tify overviews of SRs or SRs that meet the inclusion criteria, that
is, if we lack research to conduct alternative A, B, or C, we will
search for primary studies. If we find at least five high-quality ran-
domized controlled trials (RCTs), non-randomized controlled trials
(NRCTs), or controlled before-and-after studies (CBAs), we will
conduct an SR of these (Review D). If we do not find at least five
of the above controlled studies, we will perform a systematic map-
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Figure 1. Potential review types based on the search results.
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Eligibility
Inclusion criteria
i. Types of participants: Persons who are 18 years or older, and
who are neither in the very early or very advanced stage of one
or more of the following: cardiovascular disease, diabetes,
chronic lung diseases, cancer, mental disorders, chronic mus-
culoskeletal disorders, osteoporosis, or impaired vision/hear-
ing; and persons who are neither in the very early nor very
acute phase of these conditions.
ii. Types of interventions: Bidirectional RPM in which patient
health data are transmitted remotely and are then evaluated
by a health care provider in the primary health services (e.g.,
general practitioners, municipal health services, home care ser-
vices). Alternatively, data evaluation can be automated, as long
as the provider will be looped in if data are of concern. RPM
must be provided within the primary health services. Devices
can be telephones, mobile telephones, videos, portable devices,
or implantable devices.
iii. Types of comparators: Standard care that does not involve
RPM; or other type of RPM.
iv. Primary outcomes: mental health (symptoms or diagnoses);
diagnosis-specific physical health; physical functioning level;
quality of life; consumption of health services (hospital
admissions, emergency care, number of bed-days, outpatient
consultations, nursing home stays, home care, and general
practitioner consultations); or health services costs.
v. Secondary outcomes: employment; education; social health
(isolation, loneliness); patient experiences; or health literacy.
Other secondary outcomes may be considered if they are sim-
ilar to the aforementioned secondary outcomes.
vi. Years: Overviews of overviews and SRs: published in 2015 and
later, to ensure the capture of the most updated technologies. If
no SRs are found, we will include primary studies published in
2010 and later.
We will assess ‘very early’ and ‘very advanced’ stages according to
the authors’ descriptions of their populations, for example, a pop-
ulation recently diagnosed would be assessed as in an early stage,
while inpatients receiving intensive care may be assessed as in an
advanced stage. If the population is mixed, for example, both chil-
dren and adults or both chronic diseases and non-chronic diseases,
studies will be included as long as≥50%meet the inclusion criteria,
or if the results are presented separately so that the outcomes
related to our populations of interest can be extracted. If the inter-
vention is mixed, for example, RPM that is conducted both in pri-
mary and specialist health service settings, studies will be included
as long as ≥50% meet the inclusion criteria, or if interventions are
reported separately.
No languages will be excluded a priori, but studies in languages
that are mastered by neither the project staff nor our colleagues will
be excluded. These will be listed in an appendix.
Exclusion criteria
i. Types of studies: Qualitative studies; non-empirical studies.
ii. Types of participants: Persons with reduced cognitive function
who may not be able to report their own health status.
iii. Types of interventions: Fully automated RPM technologies
that do not require input from health care providers; purely
internet-based programs; mobile applications on phones or
tablets; treatment provided at a distance; RPM in which the
first provider involved is a specialist or working within the
specialist health services.
iv. Outcomes: Medication adherence; treatment adherence.
v. Settings: Reviews and studies that explicitly exclude Norway or
the part of the world in which Norway is located, for example,
studies of low- and middle-income countries.
Methodological quality criteria
We will only include reviews that are of high methodological qual-
ity. To our knowledge, there is not yet a quality or reporting
checklist for overviews of overviews. If we conduct Review A,
we will modify our research center’s [Norwegian Institute of
Public Health (NIPH)] existing checklist for SRs, as suggested
by recent research regarding this lack of quality standards
(Ballard and Montgomery, 2017, Hunt et al., 2018). To be assessed
as high quality in the NIPH checklist, reviews must demonstrate a
clear research question, adequate search design, appropriate analy-
sis of results and assess the quality of the original studies. If we
conduct Review B or C, we will use the NIPH checklist for SRs
(based on the Center for Evidence-based Medicine checklist). If
we conduct Review D, we will use the Cochrane Risk of Bias
tool for RCTs (Higgins et al., 2011), and Cochrane’s Effective
Practice and Organisation of Care checklist for NRCTs and
CBA trials. Two researchers will independently assess methodo-
logical quality, and disagreements will be resolved through discus-
sion. A third researcher will be engaged if disagreements cannot be
resolved.
Search strategy and study selection
We recognize that a wide range of terms are in use to describe what
we have operationalized as RPM, but we expect that many studies
using the term RPM will not meet our inclusion criteria. We have
therefore developed a comprehensive search strategy, available
from the authors upon request, that also includes terms such
as telehealth, home monitoring, remote care, eHealth, and
mHealth. An information specialist will perform the electronic
database search, in the following databases: Cochrane Library,
Epistemonikos, MEDLINE (OVID), EMBASE, and Web of
Science. Two researchers will independently review titles and
abstracts for potentially relevant studies. Conflicts will be resolved
through discussion. The full texts of potentially relevant studies
will be obtained and read independently by two researchers, with
a third researcher available to resolve conflicts.
Data extraction, synthesis, and presentation
One researcher will perform data extraction and another will check
her extraction, usingCovidence software. In Reviews A, B, andC, we
will use the results provided by the review authors. We will group
data from the reviews by chronic disease type and summarize the
evidence presented. The following data will be extracted from the
included reviews: title, author, research question, time period of
the search, number of included studies (and participants), study
designs included, methodological quality, population and context,
details of RPM, comparison(s), outcomes, and results of the reviews.
If no overviews or SRs are identified, we will redo our search to
include primary studies. At least five included controlled studies
(RCTs, NRCTs, or CBAs) will result in a SR (Review D). If the
majority are assessed as having high methodological quality,
as described inMethodological quality criteria, we will only extract
data from these. The following data will be extracted: title, author,
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study design, context, number of and characteristics of partici-
pants, RPM details, comparison, outcomes, and results. Results
of each outcome will be reported separately and grouped by
chronic disease. We will analyze the dichotomous outcome
measures by calculating the relative risk and the 95% confidence
interval (CI).Wewill analyze continuous outcomes using themean
difference with 95% CI or standardized mean difference, if the out-
come measures have different units or scales of measurements.
Results from different study designs will be analyzed separately.
We will perform meta-analyses if primary studies have the same
outcomes and are sufficiently similar in terms of population, inter-
vention, comparison, and effect measurement. Random effects
models will be used, given our expectation that RPM will have dif-
ferent effects in different contexts and with different populations
(Borenstein et al., 2009). We will use the Mantel–Haenszel method
for dichotomous outcomes and the inverse-variance method for
continuous outcomes. We will evaluate statistical heterogeneity
with Chi-square test and I-square values. Subgroup analyses will
be conducted if possible on: participants with single chronic
diseases versus multiple, follow-up by health personnel versus
non-health personnel, and different types of RPM.
Preliminary searches suggest we will find studies that allow us to
conduct Review A, B, C, or D. We therefore consider Review E
unlikely. Nevertheless, if we do not identify five or more controlled
studies, we will conduct a systematic mapping review that provides
an overview of the empirical research available regarding our
research question. The results of a mapping review will be based
on the same literature search as for Review D and will be summa-
rized in text and tables. The methodological framework suggested
by Arksey and O’Malley (2005) and further developed by Levac
et al. (2010) will guide the mapping review. This framework
includes the following steps: after identification of the research
question, study selection, and data extraction, data will be sorted
and summarized in close consultation with the commissioner.
Data summaries are simpler than in SRs; in exchange, the sum-
mary of results will be highly tailored to the DoH’s interests and
needs for information.
Assessment of the quality of evidence in included studies
The Grading of Recommendations Assessment, Development, and
Evaluation (GRADE) method is a tool to assess confidence in up
to seven of the most frequently reported primary outcomes. If
we conduct Review A, B, or C, we will use the review authors’
own GRADE assessments, if available. If it is not available, we will
use information from the reviews to perform a GRADE assess-
ment. If we conduct Review D, we will perform a GRADE assess-
ment. We will use study design as a starting point and then
consider the following five criteria for each outcome measure:
methodological study quality, degree of consistency, directness,
dissemination bias, and precision of data. Upgrading is possible
for outcomes from observational studies if there is a large effect
estimate, a dose-response gradient, or if all plausible effect modi-
fiers, if present, would reduce the effect. More descriptions of how
we use GRADE to assess confidence in results can be found in
Guyatt et al. (2011). Certainty of the evidence is not assessed in
mapping reviews (Review E).
Discussion
This flexible protocol is for what may be the first SR of RPM
strategies among chronic disease patients that uses a definition
of RPM developed by a national commissioning organization,
so as to be most relevant to national health policy priorities.
One of five possible SR types will be conducted, according to
the results of the literature search. Results of the review will
describe the clinical efficacy of bidirectional RPM administered
in the primary health services, for up to eight different groups
of chronic disease patients. Separating results by chronic disease
group will help policy-makers prioritize RPM for the groups in
Norway that are most likely to benefit. We expect that results will
also be informative for the Norwegian DoH as it moves forward
with recommendations to municipal health services. Any gaps we
identify in the evidence can also inform future implementation
research.
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